Gary K. Steinberg

Publication Details

  • Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome C release STROKE Zhao, H., Yenari, M. A., Sapolsky, R. M., Steinberg, G. K. 2004; 35 (2): 572-577

    Abstract:

    We showed previously that Bcl-2 overexpression with the use of herpes simplex viral (HSV) vectors improved striatal neuron survival when delivered 1.5 hours after stroke but not when delivered 5 hours after stroke onset. Here we determine whether hypothermia prolongs the therapeutic window for gene therapy.Rats were subjected to focal ischemia for 1 hour. Hypothermia (33 degrees C) was induced 2 hours after insult and maintained for 3 hours. Five hours after ischemia onset, HSV vectors expressing Bcl-2 plus beta-gal or beta-gal alone were injected into each striatum. Rats were killed 2 days later.Striatal neuron survival of Bcl-2-treated, hypothermic animals was improved 2- to 3-fold over control-treated, hypothermic animals and Bcl-2-treated, normothermic animals. Neuron survival among normothermic, Bcl-2-treated animals was not different from control normothermics or control hypothermics. Double immunostaining of cytochrome c and beta-gal demonstrated that Bcl-2 plus hypothermia significantly reduced cytochrome c release.Postischemic mild hypothermia extended the time window for gene therapy neuroprotection using Bcl-2 and reduced cytochrome c release.

    View details for DOI 10.1161/01.STR.0000110787.42083.58

    View details for Web of Science ID 000188669500057

    View details for PubMedID 14726551

Stanford Medicine Resources:

Footer Links: